See what's next from Salugen.
Salugen's development pipeline is extremely robust and promising. The table below shows some of the key nutrigenomics products Salugen has in development. As a pioneer in individualized medicine, we are committed to reinvesting a significant percentage of our revenues back into research and development—a practice that is proving successful in bringing the world's first and only DNA-customized wellness products to market.
| Healthcare Concern |
Brand Name |
Anticipated Commercial Availability |
| Weight Management and Body Recomposition |
GenoTrim™ |
GenoTrim - Pilot tested in March 2006
(Holland - The Netherlands)
Commercial Availability in the U.S. Q3 2007 |
| Overall Wellness involving heart health, anti-aging, skin, hair, and nails |
SpaGen |
SpaGen - November 2006
(US) |
| Narcotic, alcohol, and recreational drug attenuation |
Haveos |
Haveos - Pilot test in April 2007; Commercial availability in early 2008
|
| Late Phase Development |
| Gastrointestinal ailment nutritional deficiencies in Celiac disease, irritable bowel and other conditions |
| Fitness and Optimal Physical/Athletic Performance |
| Bariatric surgery-related nutritional deficiencies |
| Early Phase Development |
| Pre-Natal Vitamins |
| Pediatric Vitamins |
